Kenneth Offit

Kenneth Offit (born February 19, 1955) is an American cancer geneticist and oncologist known for his discoveries with respect to the genetic bases of breast, colorectal, and lymphoid cancers. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute and Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College. He was previously a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.

Offit has garnered numerous honors for his contributions to the prevention and management of cancer. In 2013, he was selected for the American Society of Clinical Oncology-American Cancer Society Award and Lecture. In 2016, he was elected as a Member of the National Academy of Medicine and appointed to the Roundtable on Genomics and Precision Health. In 2018, he was named a Fellow of the American Society of Clinical Oncology. In 2021, he was elected a Fellow of the American Association for the Advancement of Science. In 2023, he was awarded University of Pennsylvania's Basser Global Prize for BRCA1 and BRCA2-related research and an Ellis Island Medal of Honor for his national professional and civic contributions. Provided by Wikipedia